Behavioral Health

Personality disorders: cluster A, B, C overview

Clinical Overview and When to Suspect Personality Disorders

— Cluster A (Weird/odd-eccentric): Paranoid, Schizoid, Schizotypal

— Cluster B (Wild/dramatic-erratic): Antisocial, Borderline, Histrionic, Narcissistic

— Cluster C (Worried/anxious-fearful): Avoidant, Dependent, Obsessive-Compulsive

— Patient with recurrent interpersonal conflict, multiple "difficult" encounters, frequent provider switching

— Splitting ("you're the only good doctor"), excessive ED visits, somatic preoccupation without organic cause

— Adult with lifelong pattern of unstable relationships, identity, or affect — not episodic

— Treatment nonadherence framed as defiance, magical thinking, or excessive dependency

Board pearl: A personality disorder diagnosis requires the pattern be stable, longstanding, and ego-syntonic — if symptoms emerged in the last 6 months after a stressor, think adjustment disorder, mood episode, or substance-induced syndrome instead.

Step 3 management: When you suspect a personality disorder in clinic, do not diagnose at the first visit — document longitudinal pattern across ≥2 encounters, screen for Axis I comorbidity, and align the entire care team on a consistent behavioral plan to prevent splitting.

Definition: Enduring, pervasive, inflexible patterns of inner experience and behavior that deviate markedly from cultural expectations, manifest in ≥2 domains (cognition, affectivity, interpersonal functioning, impulse control), with onset by adolescence/early adulthood, causing distress or functional impairment.

DSM-5 cluster framework (mnemonic: Weird, Wild, Worried):

When to suspect on Step 3:

Epidemiology: ~9–15% US prevalence; borderline ~1.6%, antisocial ~3% (M>F), OCPD most common cluster C.

Ambulatory red flags: chronic suicidality without completed attempts (BPD), legal entanglements since teens (ASPD), rule-rigidity sabotaging work (OCPD), refusing to make decisions without family input (Dependent).

Comorbidity is the rule: mood, anxiety, substance use, eating disorders — these often bring patients to care first; the personality disorder explains why treatment keeps failing.

Presentation Patterns and Key History

— Paranoid: pervasive distrust, reads malevolence into benign acts, holds grudges, suspects spouse infidelity without basis. Refuses labs "because they'll be used against me."

— Schizoid: solitary by preference, no desire for close relationships, flat affect, anhedonia for social contact. Often presents only when forced (employer, family).

— Schizotypal: odd beliefs (magical thinking, telepathy), ideas of reference, eccentric dress, social anxiety that does not improve with familiarity. Genetic link to schizophrenia.

— Antisocial: ≥18 yo with conduct disorder before 15; deceitfulness, impulsivity, aggression, lack of remorse, irresponsibility. Legal/financial chaos.

— Borderline: frantic abandonment avoidance, unstable intense relationships, identity disturbance, self-harm/suicidality, affective instability lasting hours, chronic emptiness, transient stress-related paranoia/dissociation.

— Histrionic: attention-seeking, sexually provocative, shallow rapidly shifting emotion, suggestible, perceives relationships as more intimate than they are.

— Narcissistic: grandiosity, need for admiration, lack of empathy, entitlement, envy, exploitation. Rage at perceived slights ("narcissistic injury").

— Avoidant: desires relationships but avoids due to fear of rejection; feels inadequate. (Contrast with schizoid.)

— Dependent: cannot make decisions, needs others to assume responsibility, urgently seeks new relationship when one ends.

— OCPD: preoccupation with order, perfectionism that impairs task completion, workaholism, rigidity, miserliness, hoarding; ego-syntonic (unlike OCD).

Key distinction: Schizoid doesn't want relationships; Avoidant wants but fears them; Schizotypal wants but is too odd to maintain them.

Board pearl: Borderline patients commonly present after a self-harm episode triggered by perceived abandonment — ask specifically about the interpersonal trigger in the preceding 24 hours.

Cluster A — odd/eccentric, low warmth:

Cluster B — dramatic/erratic:

Cluster C — anxious/fearful:

Physical Exam Findings and Mental Status Assessment

— Schizotypal: ill-fitting or bizarre clothing, amulets, idiosyncratic grooming

— Histrionic: provocative or theatrical dress, dramatic gestures

— Narcissistic: meticulously curated appearance, name-dropping

— Borderline: visible self-harm scars (forearms, thighs), tattoos with abandonment themes

— Antisocial: tattoos with violent/gang motifs, prison-acquired marks, signs of IV drug use

— OCPD: rigidly neat, hyper-punctual or paradoxically late from over-checking

— Splitting (idealizing one nurse, devaluing another) → BPD

— Charming, glib, manipulative, lying detected on collateral → ASPD

— Demanding VIP treatment, devaluing trainees → Narcissistic

— Refuses to disrobe, suspicious of recording → Paranoid

— Affect: labile (BPD, histrionic), constricted (schizoid, paranoid), inappropriate (schizotypal)

— Thought content: ideas of reference, magical thinking (schizotypal); persecutory but not delusional intensity (paranoid); grandiose self-view (narcissistic)

— Insight/judgment: typically poor; ego-syntonic traits are not seen as problems

— Check for self-injury wounds, ligature marks, overdose stigmata in cluster B

— Screen for STIs, hepatitis C, HIV in ASPD and BPD (impulsivity, IVDU, high-risk sex)

— Assess for malnutrition, dehydration in severe schizoid/avoidant social isolation

Step 3 management: Document objective MSE findings and specific behaviors (verbatim quotes when possible) rather than pejorative labels — "patient stated 'you're trying to poison me'" is defensible; "patient is paranoid and difficult" is not.

Board pearl: Self-harm in BPD is typically non-suicidal self-injury (NSSI) for affect regulation — but 10% of BPD patients complete suicide, so every episode requires risk assessment.

Personality disorders have no pathognomonic physical findings — the "exam" is the mental status examination (MSE) plus collateral observation of behavior across visits.

General appearance clues:

Behavior with staff:

MSE patterns:

Hemodynamic/medical caveats:

Diagnostic Workup — Initial Evaluation and Screening

— Ruling out medical mimics of behavioral change

— Identifying treatable comorbid Axis I conditions

— Establishing safety

— Full psychiatric history with timeline establishing onset by adolescence/early adulthood

— Collateral information from family, prior records, pharmacy — essential because patients underreport or distort

— Substance use screen: urine drug screen, alcohol use (AUDIT-C), CAGE

— Suicide/violence risk assessment at every visit for cluster B

— CBC, CMP, TSH — hypothyroidism, electrolyte derangement, hepatic encephalopathy

— B12, folate — especially in elderly with new "personality change"

— HIV, RPR — neurosyphilis, HIV encephalopathy

— Ammonia if hepatic disease suspected

— Ceruloplasmin in young patient with new personality/movement changes → Wilson disease

— Urine/serum toxicology including stimulants, PCP, anabolic steroids

— SCID-5-PD structured interview — gold standard for research

— PID-5 (Personality Inventory for DSM-5) — dimensional self-report

— McLean Screening Instrument for BPD — brief 10-item screen

— PHQ-9, GAD-7 for comorbidities

Key distinction: A new personality change in adulthood is not a personality disorder until you've excluded frontal lobe lesion, FTD, hypothyroidism, substance use, Wilson disease, neurosyphilis, and HIV. True personality disorders are longstanding from youth.

Board pearl: First-episode "personality change" in a patient >40 mandates organic workup — the boards love frontotemporal dementia presenting as new disinhibition or apathy mistaken for ASPD/schizoid traits.

Personality disorders are clinical diagnoses — no lab, imaging, or biomarker confirms them. Workup is aimed at:

Required initial evaluation:

Labs to exclude organic mimics of new personality change:

Screening instruments (not diagnostic alone):

Imaging: Not routine. CT/MRI brain only if new-onset behavioral change, focal neuro signs, head trauma, age >40 with first presentation — consider frontotemporal dementia, tumor, stroke.

Diagnostic Workup — Confirmatory Approach and Differential Refinement

— Patterns must be evident across ≥2 settings (work, home, relationships) and multiple visits

— Single-encounter diagnosis is discouraged; document trajectory over weeks–months

— SCID-5-PD: clinician-administered, ~1–2 hours

— IPDE (International Personality Disorder Examination) — WHO endorsed

— DIPD-IV — research-grade

— Two-step: (1) Level of personality functioning in self (identity, self-direction) and interpersonal (empathy, intimacy) domains; (2) Pathological trait domains — negative affectivity, detachment, antagonism, disinhibition, psychoticism

— Tested on Step 3 conceptually; categorical DSM-5 Section II remains primary

— Bipolar II vs BPD: mood episodes last days–weeks in bipolar, hours in BPD; identity disturbance/abandonment fear are BPD-specific

— Schizophrenia vs schizotypal: schizotypal has no frank psychosis sustained; transient micro-psychotic episodes possible

— Social anxiety vs avoidant PD: avoidant is pervasive across all relationships; social anxiety is situational, often performance-based

— OCD vs OCPD: OCD = ego-dystonic obsessions/compulsions with insight; OCPD = ego-syntonic rigidity, no true obsessions

Step 3 management: Before locking in a personality disorder diagnosis, treat the comorbid Axis I disorder first (e.g., MDD, PTSD, substance use). Many "personality" traits attenuate substantially once depression or active substance use is controlled.

Board pearl: A patient with mood lability who responds robustly to lithium and has discrete multi-day episodes has bipolar II, not BPD — the duration of mood states is the single best discriminator on exam stems.

Longitudinal observation is the true confirmatory "test":

Structured diagnostic interviews (when diagnosis is unclear or has medicolegal/disability implications):

DSM-5 Alternative Model for Personality Disorders (AMPD, Section III):

Differentiating from Axis I disorders that mimic:

Neuropsychological testing: consider when cognitive impairment, TBI history, or atypical features blur the picture.

Risk Stratification and Management Logic

— Suicide risk: highest in BPD (8–10% lifetime completion) and comorbid MDD/SUD; assess at each visit

— Violence/homicide risk: ASPD, paranoid PD with persecutory focus, narcissistic PD after injury

— Self-neglect: severe schizoid, avoidant, dependent (when caregiver lost)

— Iatrogenic harm: polypharmacy, opioid misuse, unnecessary procedures driven by somatic complaints (BPD, histrionic)

— Tier 1 (foundation): Psychotherapy is first-line for all personality disorders. Medications are adjunctive, targeting comorbidities or specific symptom domains.

— Tier 2: Treat comorbid Axis I disorders aggressively (MDD, anxiety, PTSD, SUD)

— Tier 3: Crisis management — safety planning, brief hospitalization only when imminent risk

— BPD: Dialectical Behavior Therapy (DBT) — gold standard; also Mentalization-Based Therapy (MBT), Transference-Focused Psychotherapy (TFP), Good Psychiatric Management (GPM)

— ASPD: limited efficacy; contingency management, cognitive therapy for substance use

— Avoidant: CBT with graded exposure, similar to social anxiety

— OCPD: CBT addressing cognitive rigidity

— Cluster A: supportive therapy, low-intensity engagement; avoid confrontation

— Consistent treatment frame: same provider, scheduled visits (not PRN), clear limits

— Avoid emergency-driven prescribing of benzodiazepines or opioids

— Team communication prevents splitting

Step 3 management: For a BPD patient who calls the clinic in crisis after every conflict, the right answer is refer to/continue DBT, establish a safety plan, schedule structured follow-up — not start a new medication or admit unless imminent risk.

Board pearl: Brief hospitalization (<72h) is preferred over prolonged admission for BPD self-harm; long stays paradoxically reinforce regression and worsen outcomes.

Risk stratification priorities:

Tiered management framework:

Evidence-based psychotherapies by cluster:

General principles:

Pharmacotherapy — Evidence-Based Use and Symptom Targets

— Affective dysregulation: SSRIs (modest), lamotrigine or topiramate (mood stability, impulsivity) — note recent meta-analyses show weaker effect than once believed

— Impulsive-behavioral dyscontrol: topiramate, lamotrigine, low-dose SGAs

— Cognitive-perceptual symptoms (transient paranoia, dissociation): low-dose second-generation antipsychotics — aripiprazole, olanzapine, quetiapine

— Avoid benzodiazepines — disinhibition, dependence, overdose risk

— Avoid tricyclics — overdose lethality in suicidal patients

— Limit quantity dispensed in suicidal patients (e.g., 1-week supply)

— Use single prescriber, single pharmacy

— Document informed consent for off-label use

— Reassess every 3 months; deprescribe if no clear benefit

Step 3 management: A BPD patient on 4 psychotropics with ongoing instability needs deprescribing and psychotherapy referral, not a 5th medication — polypharmacy in BPD is a quality-of-care marker on boards.

Board pearl: Benzodiazepines in BPD are the wrong answer almost every time — they worsen impulsivity, self-harm, and overdose risk; choose DBT or a non-addictive alternative.

Core principle: No FDA-approved medication for any personality disorder. All pharmacotherapy is off-label, symptom-targeted, and adjunctive to psychotherapy.

Borderline PD — symptom-targeted approach:

Schizotypal PD: low-dose SGAs (risperidone, olanzapine) for cognitive-perceptual symptoms; SSRIs for social anxiety component.

Avoidant PD: SSRIs/SNRIs as in social anxiety disorder — sertraline, paroxetine, venlafaxine.

OCPD: SSRIs only if comorbid OCD or depression; rigidity itself doesn't respond.

Paranoid, schizoid, narcissistic, histrionic, dependent: no clear pharmacotherapy; treat comorbidities.

ASPD: pharmacotherapy targets comorbid SUD (naltrexone, buprenorphine), aggression (mood stabilizers, SGAs in select cases). Avoid stimulants unless comorbid ADHD without active SUD.

Prescribing safety in PD:

Expanded Psychotherapy and Behavioral Interventions

— Four modules: mindfulness, distress tolerance, emotion regulation, interpersonal effectiveness

— Components: individual therapy + skills group + phone coaching + therapist consultation team

— Reduces self-harm, suicide attempts, hospitalizations; ≥1 year typical course

— Builds capacity to understand mental states of self/others

— Effective for BPD; ~18 months

— Psychodynamic, twice-weekly, addresses object relations through transference

— Generalist-deliverable model; structured case management + psychoeducation; non-inferior to specialized therapies for BPD in some trials — high yield for primary care/Step 3

— Avoidant PD: graded exposure to feared social situations

— OCPD: behavioral experiments to challenge perfectionism

— ASPD: contingency management for substance use

— Written treatment contract clarifying expectations, between-session contact, emergencies

— No secrets policy with treatment team

— Address splitting through team communication

— Limit setting without rejection — "I won't do X and I'm here next Tuesday"

Step 3 management: When a board question asks the best long-term treatment for BPD, the answer is DBT (or MBT/TFP/GPM); medication is almost never the primary answer.

Board pearl: GPM is increasingly the preferred answer when "specialist DBT not available" — it's evidence-based, generalist-friendly, and explicitly endorsed by APA guidance.

Dialectical Behavior Therapy (DBT) — Linehan, gold standard for BPD:

Mentalization-Based Therapy (MBT):

Transference-Focused Psychotherapy (TFP):

Good Psychiatric Management (GPM):

Schema Therapy: integrative; helpful in BPD, narcissistic, avoidant

CBT applications:

Group therapy: avoid for paranoid, schizoid; useful for BPD (DBT skills), avoidant (social skills), ASPD (court-mandated programs of mixed efficacy)

Family/couples therapy: dependent PD, BPD with high-conflict partners

Therapeutic frame essentials:

Special Populations — Elderly and Renal/Hepatic Impairment

— Some cluster B traits attenuate with age (impulsivity, antisocial behavior) — "burnout" phenomenon, especially ASPD and BPD by 5th–6th decade

— Cluster A and C traits often persist or worsen with isolation, bereavement, cognitive decline

— Schizoid and paranoid traits may merge with paranoid responses to sensory loss (hearing, vision)

— Frontotemporal dementia (behavioral variant): disinhibition, apathy, loss of empathy mimicking ASPD/narcissistic

— Stroke (especially frontal, right hemisphere): emotional lability, disinhibition

— Delirium: fluctuating, acute — always rule out first

— Late-life depression: irritability, dependency may mimic PD

— Workup: MRI brain, neuropsych testing, TSH, B12, RPR

— Start low, go slow; elderly more sensitive to antipsychotic EPS, metabolic effects, anticholinergic load

— Avoid antipsychotics in dementia (FDA black box, increased mortality) — use only when behavioral interventions fail and risk is significant

— Avoid benzodiazepines — falls, delirium, cognitive decline (Beers criteria)

— Lithium: contraindicated in significant CKD; renally cleared

— Lamotrigine: dose adjust in severe renal impairment

— Gabapentin, topiramate: dose adjust

— SSRIs generally safe; paroxetine anticholinergic — avoid in elderly

— Valproate, carbamazepine: hepatotoxic — avoid or monitor LFTs

— Duloxetine: avoid in cirrhosis

— Prefer sertraline, escitalopram, lamotrigine with appropriate adjustments

Step 3 management: A 72-year-old with new-onset disinhibition and inappropriate sexual comments needs MRI brain and neuropsych testing for FTD, not a personality disorder diagnosis.

Board pearl: BPD self-harm rates decline with age, but completed suicide risk persists — never assume elderly BPD patients are "burned out" without explicit assessment.

Personality disorders in older adults:

New-onset "personality change" in elderly is NOT a personality disorder:

Pharmacotherapy adjustments:

Renal impairment:

Hepatic impairment:

Special Populations — Pregnancy, Adolescents, and Other Subgroups

— BPD pregnancies have higher rates of preterm birth, low birth weight, postpartum depression, impaired attachment

— Psychotherapy (DBT, MBT) is first-line and safe throughout pregnancy

— Medications: weigh teratogenicity vs maternal stability

— Valproate: contraindicated (neural tube defects, IQ reduction) — never in reproductive-age women without strict contraception

— Topiramate: cleft palate risk; avoid if possible

— Lithium: Ebstein anomaly risk small; reasonable in severe bipolar with planning

— SSRIs: sertraline preferred; paroxetine avoided (cardiac defects)

— SGAs: olanzapine, quetiapine relatively safer; monitor for gestational diabetes

— Postpartum: high relapse risk — schedule visit within 1–2 weeks, screen with EPDS

— DSM-5 permits diagnosing personality disorders before 18 if features have persisted ≥1 year (except ASPD, which requires age ≥18)

— BPD in adolescents is valid and treatable — early DBT for adolescents (DBT-A) reduces self-harm

— Conduct disorder in adolescents <18 = precursor to ASPD; childhood-onset (<10) has worse prognosis

— Avoid premature diagnostic labeling that may stigmatize

— Behaviors normative in one culture may appear pathological in another (e.g., family interdependence vs dependent PD)

— Trauma exposure, immigration stress, racism can mimic paranoid features

— Higher rates of BPD diagnosis in this population may reflect minority stress and trauma rather than personality pathology — assess carefully

— ASPD prevalence in incarcerated males ~50%; overlaps with psychopathy (Hare PCL-R)

— Distinguish ASPD from psychopathy: psychopathy adds callousness, lack of remorse, glibness

Step 3 management: A pregnant patient with BPD on valproate needs immediate switch (preconception ideally) to safer alternative + folate supplementation + MFM referral — valproate teratogenicity is a recurring board item.

Board pearl: Conduct disorder before age 15 is required for ASPD diagnosis — no childhood conduct symptoms = not ASPD.

Pregnancy and postpartum:

Adolescents:

Cultural considerations:

LGBTQ+ patients:

Forensic populations:

Complications and Adverse Outcomes

— Suicide: 8–10% lifetime completion; NSSI in 70–80%

— Substance use disorders in 50–65%

— Eating disorders, especially bulimia

— Unstable employment, relationships, finances

— Higher rates of intimate partner violence (victim and perpetrator)

— Medical complications of self-harm: infection, scarring, accidental death

— Criminal recidivism, incarceration

— Premature mortality from violence, accidents, substance use

— Higher rates of HIV, HCV, STIs from IVDU and unprotected sex

— TBI from violence

— Suicide risk during narcissistic injury (job loss, divorce, public humiliation) — often impulsive and lethal

— Substance use, particularly stimulants and alcohol

— Social isolation, occupational impairment

— Schizotypal: ~25% develop schizophrenia spectrum disorder

— Paranoid: litigation, work conflict, missed medical care due to mistrust

— Avoidant: chronic depression, social isolation, anxiety disorders

— Dependent: tolerance of abusive relationships, decision paralysis

— OCPD: burnout, cardiovascular morbidity from chronic stress, marital discord

— Polypharmacy without symptom improvement

— Opioid use disorder from chronic pain prescribing (BPD, histrionic somatic presentations)

— Benzodiazepine dependence

— Unnecessary procedures driven by somatic preoccupation

— Provider burnout and countertransference errors (rejection, over-involvement)

Step 3 management: A BPD patient on chronic opioids and benzodiazepines presenting with overdose requires MAT for opioids, benzodiazepine taper, DBT referral, and coordinated care plan — not continued PRN escalation.

Board pearl: The single greatest mortality risk in BPD is suicide, and the single greatest mortality risk in ASPD is violence/accidents — both reduce life expectancy by ~20 years.

Borderline PD:

Antisocial PD:

Narcissistic PD:

Cluster A:

Cluster C:

Iatrogenic complications across all PDs:

When to Escalate Care — Hospitalization, Consults, and Crisis Triage

— Imminent suicide risk with plan, intent, means

— Active psychosis (rare in PD but possible in schizotypal, transient BPD)

— Severe self-harm requiring medical stabilization

— Inability to maintain safety in outpatient setting despite intensive support

— Acute danger to others (rare; ASPD typically managed forensically, not psychiatrically)

— Brief (24–72h) crisis stabilization preferred

— Long stays → regression, dependency, iatrogenic worsening

— Use partial hospitalization (PHP) or intensive outpatient (IOP) as step-down

— Outpatient (weekly therapy) → IOP (3 days/week) → PHP (5 days/week) → inpatient → residential

— DBT programs often delivered at IOP level

— Psychiatry consult for diagnostic clarification, medication optimization, safety planning

— DBT-trained therapist for BPD

— Addiction medicine for comorbid SUD

— Social work for housing, benefits, legal issues — especially ASPD, severe BPD

— Pain medicine for chronic pain with PD comorbidity to avoid opioid pitfalls

— Establish safety plan (Stanley-Brown): warning signs, internal coping, social contacts, professional contacts, means restriction

— Means restriction counseling: firearms, medications

— Schedule follow-up within 7 days of ED discharge — strongest predictor of reduced re-attempt

CCS pearl: For a BPD patient in the ED after superficial cutting without suicidal intent, the orders are: medical wound care, mental status exam, suicide risk assessment, safety plan with patient and family, DBT/outpatient follow-up within 1 week, naloxone if opioid access — not automatic admission.

Step 3 management: Post-ED follow-up within 7 days is the high-yield secondary prevention answer for any psychiatric discharge — it cuts re-attempt rates substantially.

Indications for inpatient psychiatric admission:

Avoid prolonged hospitalization for BPD:

Levels of care continuum:

Consults and referrals:

Emergency department disposition:

Key Differentials — Within Personality Disorder Clusters

— Paranoid: distrust without odd beliefs or perceptual distortions

— Schizoid: detachment without paranoia or odd beliefs; prefers solitude

— Schizotypal: detachment plus odd beliefs, magical thinking, perceptual distortions, ideas of reference

— Overlap with schizophrenia spectrum: schizotypal has no sustained psychosis; schizoid lacks negative symptoms severity

— Antisocial: rule violation, criminality, lack of remorse, conduct disorder history

— Borderline: affective instability, abandonment fear, identity disturbance, self-harm — internalized distress

— Histrionic: attention-seeking via seductiveness, theatricality; shallow affect, suggestible

— Narcissistic: grandiosity, entitlement, lack of empathy, envy

— Overlap: BPD + ASPD common (especially in men with BPD); narcissistic + ASPD = "malignant narcissism"

— Avoidant: avoids relationships from fear of rejection, feels inadequate; wants closeness

— Dependent: clings to existing relationships, can't make decisions alone, urgent replacement seeking

— OCPD: rigidity, perfectionism, control; ego-syntonic; not the same as OCD

— BPD vs histrionic: both attention-seeking, but BPD has identity disturbance, abandonment fear, self-harm; histrionic is more shallow and seductive

— Narcissistic vs ASPD: both lack empathy; ASPD adds criminality and reckless disregard for safety

— Avoidant vs dependent: avoidant avoids initiating; dependent clings once attached — frequently co-occur

— Schizoid vs avoidant: schizoid doesn't want contact; avoidant wants but fears it

Key distinction: OCPD ≠ OCD. OCPD: ego-syntonic perfectionism, rigidity, no true obsessions/compulsions. OCD: ego-dystonic intrusive obsessions with compulsive rituals to neutralize anxiety. They co-occur in ~20% but are distinct disorders.

Board pearl: When a stem describes someone "wanting friends but too anxious to make them" → avoidant PD; "not interested in friends" → schizoid PD.

Distinguishing within Cluster A:

Distinguishing within Cluster B:

Distinguishing within Cluster C:

Common diagnostic confusions:

Key Differentials — Outside Personality Disorder Spectrum

— Bipolar II vs BPD: mood episodes lasting days–weeks vs hours; BPD has identity disturbance, abandonment fear, chronic emptiness

— MDD with anxious distress may mimic avoidant or dependent traits — resolves with treatment

— Cyclothymia vs BPD: cyclothymia is purely mood; BPD has interpersonal core

— Schizophrenia: sustained psychosis, negative symptoms; schizotypal lacks frank psychosis

— Delusional disorder: encapsulated delusions without other symptoms; paranoid PD has suspiciousness without delusional intensity

— Social anxiety disorder: situational, performance-focused; avoidant PD is pervasive across all relationships

— GAD: worry about real-life concerns; OCPD is rigidity and perfectionism

— OCD: ego-dystonic obsessions/compulsions; OCPD is ego-syntonic

— Complex PTSD: chronic trauma → affect dysregulation, negative self-concept, interpersonal difficulty — substantial overlap with BPD; trauma history and re-experiencing distinguish

— PTSD: discrete trauma, re-experiencing, avoidance, hyperarousal

— Adjustment disorder: ≤6 months from stressor; not pervasive lifelong pattern

— Autism spectrum: social communication deficits from childhood; restricted interests — distinguish from schizoid (autism wants connection but lacks skills) and schizotypal (odd beliefs vs ASD's literal thinking)

— ADHD: impulsivity, emotional dysregulation overlap with BPD; ADHD onset in childhood with attention/executive features

— Active substance use can mimic any PD; reassess after ≥3 months sobriety

— Frontotemporal dementia, Huntington disease, Wilson disease, lupus cerebritis, neurosyphilis, HIV encephalopathy, brain tumor, TBI, hypothyroidism, Cushing syndrome

Key distinction: Complex PTSD and BPD share 60% phenotypic overlap. The differentiating features are trauma history with re-experiencing (PTSD) vs abandonment-driven instability with identity disturbance (BPD); modern care often treats both dimensions.

Board pearl: New behavioral change in middle age with executive dysfunction and disinhibition → bvFTD, not personality disorder; order MRI brain and neuropsych.

Mood disorders:

Psychotic disorders:

Anxiety disorders:

Trauma- and stressor-related:

Neurodevelopmental:

Substance-induced:

Medical mimics:

Long-Term Plan — Secondary Prevention and Discharge

— Outpatient psychiatry follow-up within 7 days of inpatient/ED discharge

— Specific therapist contact (name, phone, date of first session)

— Safety plan in writing (Stanley-Brown), copy to patient and family

— Means restriction: firearm removal/storage, lethal medications limited

— Naloxone prescription if any opioid use history

— Crisis line numbers: 988 (Suicide & Crisis Lifeline), local mobile crisis

— Deprescribe medications without clear benefit (polypharmacy reduction)

— Avoid benzodiazepines as discharge medications in BPD/ASPD

— Limited quantity (1–2 weeks) for any potentially lethal medication in suicidal patients

— Document single prescriber, single pharmacy plan

— Warm handoff to outpatient team — phone call, not just fax

— Shared treatment plan among PCP, psychiatrist, therapist

— Address splitting risk by aligned communication

— Family psychoeducation when appropriate (BPD family programs: NEABPD, Family Connections)

— Continue MAT for opioid/alcohol use disorder

— SSRIs for comorbid depression/anxiety

— Sleep hygiene; avoid hypnotic dependence

— Vocational rehabilitation for chronic disability from PD

— Housing support for severe cases

— Disability benefits navigation if functionally impaired

— BPD: majority achieve remission (no longer meet criteria) by 10-year follow-up with treatment; functional recovery slower

— ASPD: criminal behavior may attenuate with age but interpersonal callousness persists

— Cluster A, C: more chronic, gradual change

Step 3 management: The single highest-yield post-discharge intervention for any psychiatric patient is outpatient follow-up within 7 days plus means restriction counseling — this is the right answer on virtually every transition-of-care question.

Board pearl: BPD has a better long-term prognosis than once believed — ~85% achieve symptomatic remission by 10 years with appropriate treatment.

Discharge planning essentials:

Medication reconciliation at discharge:

Care coordination:

Comorbidity management:

Functional rehabilitation:

Long-term prognosis:

Follow-Up, Monitoring, and Counseling

— Stable PD with established therapy: monthly to quarterly PCP/psychiatry visits

— Recent crisis or medication change: weekly to biweekly

— Post-hospitalization: within 7 days, then weekly × 1 month

— Suicidal ideation (C-SSRS or equivalent) — every visit in BPD

— Self-harm in past interval

— Substance use (urine screen periodically)

— Medication adherence and side effects

— Interpersonal functioning, work, relationships

— Comorbid symptoms (PHQ-9, GAD-7)

— SGAs: weight, BMI, fasting glucose, lipid panel, A1c at baseline, 3 months, then annually; metabolic syndrome surveillance

— Lithium: levels, TSH, BUN/Cr, calcium every 3–6 months

— Valproate: LFTs, CBC, levels; pregnancy testing in reproductive-age women

— Lamotrigine: rash surveillance during titration (SJS/TEN risk); slow titration mandatory

— SSRIs: monitor for activation, sexual side effects, hyponatremia in elderly

— Validate distress while limiting maladaptive behaviors — DBT dialectic

— Avoid power struggles with paranoid, narcissistic, OCPD patients — provide options

— Set clear, written limits with cluster B; revisit consistently

— Psychoeducation about diagnosis helps BPD patients (reduces shame, improves engagement); use cautiously with ASPD, narcissistic (may weaponize)

— Family psychoeducation (NEABPD Family Connections) reduces caregiver burden

— Respect patient confidentiality while engaging family for safety

— Skills groups (DBT skills), supported employment, peer support

Step 3 management: A BPD patient on quetiapine for 6 months who has gained 15 kg with A1c 6.2% needs metabolic workup, switch to lower-risk SGA (e.g., aripiprazole) or deprescribe, lifestyle counseling, and metformin consideration — metabolic monitoring is non-negotiable.

Board pearl: Lamotrigine rash within 2–8 weeks of initiation requires immediate discontinuation — Stevens-Johnson syndrome risk; this is high-yield on Step 3 stems.

Follow-up cadence:

At each visit, screen for:

Medication monitoring:

Counseling pearls:

Family involvement:

Rehabilitation:

Ethical, Legal, and Patient Safety Considerations

— Standard confidentiality applies

— Mandatory exceptions: imminent danger to self/others, child/elder/dependent adult abuse, court orders

— Tarasoff duty (in most states): warn/protect identifiable victims when patient makes credible threat — particularly relevant in ASPD, paranoid PD with persecutory focus

— Personality disorder does not equal incapacity; assess decision-specific capacity (understanding, appreciation, reasoning, choice)

— BPD patient refusing admission despite suicidal ideation: assess capacity; involuntary hold if criteria met (danger to self, gravely disabled, mental illness)

— Document capacity assessment clearly

— Criteria vary by state but generally: mental illness + danger to self/others or grave disability

— Personality disorder alone is typically insufficient — requires acute risk

— Time-limited holds (typically 72h); judicial review for extension

— All PD pharmacotherapy is off-label — document discussion of risks, benefits, alternatives, off-label status

— Particularly important for antipsychotics (metabolic, EPS, tardive dyskinesia) and mood stabilizers (teratogenicity)

— Highest-risk window for suicide is the 30 days post-discharge

— Failure to schedule 7-day follow-up is a documented patient safety lapse

— Medication errors at transition: reconcile and limit lethal supply

— Cluster B patients (especially BPD, histrionic, narcissistic) may test boundaries — gifts, after-hours contact, requests for special treatment

— Maintain consistent frame; consult colleagues when boundary issues arise

— Document boundary discussions

— Child abuse/neglect (especially with ASPD parents, severe BPD with impaired parenting)

— Impaired driving, certain communicable diseases (state-dependent)

— Personality disorder rarely meets disability criteria alone; functional impairment must be documented

— ASPD in forensic settings: criminal responsibility generally not negated by ASPD diagnosis

Step 3 management: A BPD patient with capacity who refuses recommended admission but has a credible safety plan, supportive family, and 24-hour follow-up arranged may be safely discharged with documentation — coercive admission against capacitated refusal is both unethical and legally risky.

Board pearl: Tarasoff duty applies to identifiable threatened victims with a credible, serious threat — generalized hostility doesn't trigger it.

Confidentiality and its limits:

Capacity assessment:

Involuntary commitment:

Informed consent for off-label psychotropics:

Transition-of-care safety:

Professional boundaries:

Mandated reporting:

Forensic and disability evaluations:

High-Yield Associations and Rapid-Fire Facts

— Clusters: A = Weird (Accusatory, Aloof, Awkward) — Paranoid, Schizoid, Schizotypal

— B = Wild (Bad, Bored, Brash, Bragging) — Antisocial, Borderline, Histrionic, Narcissistic

— C = Worried (Cowardly, Clingy, Compulsive) — Avoidant, Dependent, OCPD

— Schizotypal ↔ schizophrenia spectrum (genetic relatives of schizophrenia)

— BPD ↔ mood disorders, substance use disorders

— ASPD ↔ substance use, ADHD

— OCPD ↔ OCD (related but distinct)

— Paranoid: projection

— Schizoid/schizotypal: fantasy, isolation of affect

— Antisocial: acting out

— Borderline: splitting, projective identification

— Histrionic: dissociation, regression

— Narcissistic: idealization/devaluation

— Avoidant: avoidance

— Dependent: regression

— OCPD: isolation of affect, intellectualization, reaction formation

— Most common PDs in clinical samples: BPD, OCPD, avoidant

— ASPD: M:F ~3:1; BPD: F:M ~3:1 (in clinical samples; community samples more equal)

— Childhood trauma (especially sexual abuse): strong association with BPD

— DBT — gold standard for BPD

— No FDA-approved drug for any PD

— Avoid benzodiazepines in BPD/ASPD

— Brief hospitalization preferred for BPD self-harm

— Lamotrigine: titrate slowly (rash risk)

— BPD + bipolar II (often misdiagnosed for each other)

— ASPD + SUD (~80%)

— Avoidant + social anxiety disorder (massive overlap)

— OCPD + OCD (~20%)

Board pearl: "Splitting" describes a patient who alternately idealizes and devalues the same person or staff member — virtually pathognomonic for borderline PD on board stems.

Key distinction: Defense mechanism mapping is a favorite Step 3 question — memorize splitting (BPD), projection (paranoid), acting out (ASPD), idealization/devaluation (narcissistic).

Mnemonics:

Genetic/family associations:

Defense mechanisms by PD:

Epidemiology snapshots:

High-yield treatment facts:

Comorbidity high-yields:

Board Question Stem Patterns

— Answer: DBT referral; safety plan; outpatient follow-up within 7 days; avoid benzodiazepines

— Hours-long mood shifts triggered by interpersonal events → BPD

— Days-to-weeks elevated mood with decreased sleep, grandiosity → Bipolar II

— Answer: ASPD; address comorbid SUD; psychotherapy of limited benefit

— Doesn't want friends, indifferent → schizoid

— Wants friends but fears rejection → avoidant

— Ego-syntonic, no true compulsions, impairs work → OCPD

— Ego-dystonic obsessions with relieving rituals → OCD

— Answer: MRI brain, neuropsych — bvFTD, not personality disorder

— Answer: warn/protect identifiable victim, notify law enforcement, document

— Answer: deprescribe and refer to DBT; not another medication

— Answer: team meeting, consistent unified plan, address splitting explicitly

Step 3 management: When the stem describes a patient idealizing the new resident and devaluing the attending after a limit was set, the answer is acknowledge splitting, hold a team meeting, present a unified treatment plan — not switch providers.

Board pearl: The Step 3 "right answer" for almost any PD question is psychotherapy first (DBT for BPD), comorbidity treatment, deprescribe polypharmacy, structured follow-up, safety planning — beware of medication-heavy distractors.

Classic BPD stem: "A 24-year-old woman presents to the ED after cutting her forearms following an argument with her boyfriend. She has had 5 prior ED visits for similar reasons. She tells you that you are 'the only doctor who has ever understood her' but yelled at the triage nurse for being 'cruel.'"

Bipolar II vs BPD stem: mood lability — ask duration of episodes

Antisocial PD stem: adult with criminal history since adolescence, deceitful, lacks remorse, charming on interview

Schizoid vs avoidant stem: solitary lifestyle

OCPD vs OCD stem: perfectionism, rigidity

Frontotemporal dementia mimicking ASPD/schizoid: 55-year-old man with new disinhibition, apathy, loss of empathy

Tarasoff stem: paranoid patient names a specific person he intends to harm

Pregnancy in BPD on valproate: switch to safer agent preconception; lamotrigine or non-pharmacologic

Polypharmacy in BPD stem: patient on 4 psychotropics with ongoing instability

Post-discharge follow-up: any psychiatric discharge — 7-day follow-up + means restriction

Splitting on inpatient unit: staff polarized about patient

One-Line Recap

Personality disorders are enduring, pervasive, ego-syntonic patterns of inner experience and behavior beginning by early adulthood, grouped into Cluster A (odd/eccentric), B (dramatic/erratic), and C (anxious/fearful), best treated with disorder-specific psychotherapy (DBT for BPD is gold standard) with medications reserved as adjuncts targeting specific symptoms or comorbidities — never as primary therapy.

— A — Weird: Paranoid (distrust), Schizoid (detached, doesn't want contact), Schizotypal (odd beliefs, magical thinking)

— B — Wild: Antisocial (rule violation, no remorse), Borderline (instability, splitting, self-harm), Histrionic (theatrical attention-seeking), Narcissistic (grandiosity, no empathy)

— C — Worried: Avoidant (wants connection but fears rejection), Dependent (clinging, decision paralysis), OCPD (ego-syntonic rigidity, ≠ OCD)

— Psychotherapy is first-line for all PDs; DBT, MBT, TFP, GPM for BPD

— No FDA-approved drug for any PD; off-label symptom-targeted use

— Avoid benzodiazepines in BPD/ASPD (disinhibition, dependence, overdose)

— Brief hospitalization preferred over prolonged admission for BPD self-harm

— 7-day post-discharge follow-up + means restriction = highest-yield safety intervention

— New-onset behavioral change in adulthood → rule out bvFTD, stroke, Wilson, neurosyphilis, hypothyroidism, substance use before diagnosing PD

— Bipolar II vs BPD: episode duration (days vs hours) is the key discriminator

— OCD vs OCPD: ego-dystonic vs ego-syntonic

— BPD has a better long-term prognosis than historically believed — ~85% remission at 10 years with treatment

— Cluster B impulsivity attenuates with age; cluster A and C tend to persist

Board pearl: When in doubt on a PD question, choose psychotherapy, treat comorbidities, deprescribe, safety plan, 7-day follow-up — these answers win the majority of Step 3 vignettes.

Step 3 management: Align the entire care team on a consistent, written behavioral plan to prevent splitting and iatrogenic harm — this systems-level intervention defines high-quality longitudinal personality disorder care.

Cluster recap:

Treatment recap:

Differential vigilance:

Prognosis: